• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

具有肿瘤靶向及穿膜效应的壳聚糖胶束的制备

刘婉婉, 张胜喻, 杨彧, 朱红艳

刘婉婉, 张胜喻, 杨彧, 朱红艳. 具有肿瘤靶向及穿膜效应的壳聚糖胶束的制备[J]. 中国药科大学学报, 2015, 46(5): 561-567. DOI: 10.11665/j.issn.1000-5048.20150508
引用本文: 刘婉婉, 张胜喻, 杨彧, 朱红艳. 具有肿瘤靶向及穿膜效应的壳聚糖胶束的制备[J]. 中国药科大学学报, 2015, 46(5): 561-567. DOI: 10.11665/j.issn.1000-5048.20150508
LIU Wanwan, ZHANG Shengyu, YANG Yu, ZHU Hongyan. Preparation of tumor-targeting chitosan micelle with transmembrane effect[J]. Journal of China Pharmaceutical University, 2015, 46(5): 561-567. DOI: 10.11665/j.issn.1000-5048.20150508
Citation: LIU Wanwan, ZHANG Shengyu, YANG Yu, ZHU Hongyan. Preparation of tumor-targeting chitosan micelle with transmembrane effect[J]. Journal of China Pharmaceutical University, 2015, 46(5): 561-567. DOI: 10.11665/j.issn.1000-5048.20150508

具有肿瘤靶向及穿膜效应的壳聚糖胶束的制备

基金项目: 国家自然科学基金资助项目(No.81202467);江苏省自然科学基金资助项目(No.BK2012232);江苏省高校优势学科建设工程资助项目;南通大学研究生科技创新计划资助项目(No.14060)

Preparation of tumor-targeting chitosan micelle with transmembrane effect

  • 摘要: 在壳聚糖(CS)表面修饰疏水基团辛基形成辛基壳聚糖(OC),然后再修饰亲水基团聚乙二醇(PEG)、肿瘤靶向配体氨基葡萄糖(DG)和穿膜肽九聚精氨酸(9R),形成DG和9R共同修饰的、同时具有肿瘤靶向性及穿膜效应的壳聚糖纳米胶束(DG/9R-PEG-OC)。核磁共振光谱分析及聚丙烯酰胺凝胶电泳检测结果证实了DG/9R-PEG-OC的成功制备;测得壳聚糖纳米胶束的粒径为151.8 nm左右、Zeta电位约为16.5 mV;透射电子显微镜照片显示该壳聚糖纳米胶束为均匀的球形结构;紫外分光光度法测定该载体的荧光素载药量约为28.2%,包封率约为75.0%,释药实验表明壳聚糖胶束具有良好的缓释作用;荧光显微镜观察显示,该DG/9R-PEG-OC胶束对肿瘤细胞尤其是葡萄糖受体高表达的肿瘤细胞HepG2具有较好的靶向性及细胞穿膜效应。故DG/9R-PEG-OC胶束可作为脂溶性抗肿瘤药物的载体用于肿瘤的靶向化学治疗。
    Abstract: Chitosan(CS)surface was modified with hydrophobic octyl groups to prepare N-octyl chitosan(nitrogen-octyl chitosan, OC). Then hydrophilic group carboxyl-polyethylene glycol-amino(PEG), tumor-targeting ligand D-glucosamine(DG), and membrane-penetrating peptide 9-D-arginine(9R)were linked to OC successively. Then the DG and 9R modified chitosan micelle(DG/9R-PEG-OC)with tumor-targeting and transmembrane effect was prepared. By hydrogen nuclear magnetic resonance spectrometer(1H NMR)and sodium dodecyl sulfate polyacryl amide gel electrophoresis(SDS-PAGE), the successful formation of DG/9R-PEG-OC was certified, with particle size of 151. 8 nm and Zeta potential of 16. 5 mV. The morphology of chitosan micelle observed by transmission electron microscope was homogeneous spherical structure. The drug loading content(DLC)(using fluorescein as a model drug)and encapsulation efficiency(EE)were about 28. 2% and 75. 0% measured by UV-visible spectrophotometer. Meanwhile, the drug showed a controlled releasing profile out of the micelle. Cellular uptake experiments indicated DG/9R-PEG-OC micelle had a significant tumor-tageting and transmembrane effects, especially on HepG2 cells, which exbihited high expression of the glucose transporter. Thus DG/9R-PEG-OC micelle could be a promising drug targeted delivery system of hydrophobic antitumor drugs.
  • [1] Brijesh KS,Sirohi R,Archana D,et al.Porous chitosan scaffolds:a systematic study for choice of crosslinker and growth factor incorporation[J].Int J Polymer Mater,2015,5(64):242-252.
    [2] Zhang L,Zhang N.Advances of chitosan and its derivatives in drug delivery system[J].Chin J New Drugs Clin Rem(中国新药与临床志),2014,33(1):9-14.
    [3] Hu HY,Zhu H.Adsorption of heavy metal ions by chitosan and its derivatives[J].Prog Chem(化学进展),2012,24(11):2212-2223.
    [4] Li SW,Tian JM,Jin J,et al.Targeted biodistribution of aminoglucose-modified doxorubicin.[J].J China Pharm Univ(中国药科大学学报),2012,43(3):266-270.
    [5] Nijsten MW,van Dam GM.Hypothesis:using the Warburg effect against cancer by reducing glucose and providing lactate[J].Med Hypotheses,2009,73(1):48-51.
    [6] Ganapathy V,Thangaraju M,Prasad PD.Nutrient transporters in cancer:relevance to Warburg hypothesis and beyond[J].Pharmacol Ther,2009,121(1):29-40.
    [7] Chen J,Chen HY,Cui SS,et al.Glucosamine derivative modified nano structured lipid carriers for targeted tumor delivery[J].J Mater Chem,2012,22:5770-5783.
    [8] Lindgren M,Hällbrink M,Prochiantz A,et al.Cell-penetrating peptides[J].Trends Pharmacol Sci,2000,21(3):99-103.
    [9] Meloni BP,Milani D,Edwards AB,et al.Neuroprotective peptides fused to arginine-rich cell penetrating peptides:neuroprotective mechanism likely mediated by peptide endocytic properties[J].Pharmacol Ther,2015,153:36-54.
    [10] Yin HQ,Zhang YH,Wang H,et al.The expression of fusion protein Myc-R9-EGFP and identification of its transmembrane ability[J].Biomed Eng(生物医学工程学杂志),2012,29(3):508-513.
    [11] Wei YF.The application of cell-penetrating peptide in algae cells transduing allogenic material[D].Shandong:Graduate School of Chinese Academy of Sciences(Marine Research Institute):2014.
    [12] Zhang N,Bai Y,Zhao JZ,et al.Preparation and penetrating effect of the polyarginine enhanced green fluorescence protein fusion protein[J].Chi J Biotechnol(生物工程学报),2013,29(11):1644-1653.
    [13] Nagahara H,Vocero-Akbani AM,Snyder EL,et al.Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27 Kip1 induces cell migration[J].Nat Med,1998,4(12):1449-1452.
    [14] Giacomelli C,Schmidt V,Borsali R.Nanocontainers formed by self-assembly of poly(ethylene oxide)-b-poly(glycerol monomethacrylate)-drug conjugates[J].Macromolecules,2007,40:2148-2157.
    [15] Morita T,Horikiri Y,Suzuki T,et al.Preparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol):characterization and application to entrapment into biodegradable microspheres[J].Int J Pharm,2001,219(1/2):127-137.
    [16] Ding Y,Wang Y,Opoku-Damoah Y,et al.Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy[J].Biomaterials,2015,72:90-103.
    [17] Shan L,Liu M,Wu C,et al.Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy[J].Int J Nanomed,2015,10:5571-5591.
计量
  • 文章访问数:  1078
  • HTML全文浏览量:  2
  • PDF下载量:  2053
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-10-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭